Literature DB >> 14759411

Surgical resection of lung metastases from epithelial tumors.

Alexandre Monteiro1, Nuria Arce, João Bernardo, Luís Eugénio, Manuel J Antunes.   

Abstract

BACKGROUND: One of the main characteristics of malignant tumors is the capability to disseminate, giving rise to local or distant metastases. Pulmonary metastases occur in almost 30% of all oncology patients, and secondary lung tumors are more frequent than primary ones. Surgical resection of metastases is now a well-established procedure, but the results vary with the histologic type of the primary tumor. We wished to identify factors affecting late survival after pulmonary metastasectomy for epithelial tumors.
METHODS: We have reviewed retrospectively data for 78 patients who underwent 101 curative resections of epithelial pulmonary metastases between January 1988 and December 2000 at our department. Potential prognostic factors affecting late survival, namely histology of the primary tumor, disease-free interval, number and size of resected lung metastases, involvement of lymph nodes, use of nonsurgical adjuvant therapy, and relapse of pulmonary metastases, were investigated.
RESULTS: There was no operative mortality, and the postoperative course was uneventful in 91.1% of the procedures. The mean disease-free interval was 48.2 +/- 59.8 months, and the mean follow-up after the first pulmonary metastasectomy was 40.8 +/- 31.5 months. Mean overall survival was 81.0 +/- 10.0 months, and 5-year and 10-year survival rates were 47.4% and 37.7%, respectively. By univariate and multivariate analyses, the disease-free interval and the prognostic grouping system proposed by the International Registry of Lung Metastases were found to significantly influence the long-term survival. Presence of symptoms also showed an important influence.
CONCLUSIONS: Resection of epithelial pulmonary metastases is safe and effective, and is associated with very low perioperative morbidity and mortality and a reasonable 5-year and 10-year survival. In the present study, the disease-free interval influenced significantly the long-term survival. Our results did not differ significantly from (and in many cases compared favorably with) those described in the literature.

Entities:  

Mesh:

Year:  2004        PMID: 14759411     DOI: 10.1016/j.athoracsur.2003.06.012

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  15 in total

1.  Applicability of Pulmonary Lobectomy in Treating Metastatic Lung Tumors.

Authors:  Tatsuro Okamoto; Hirokazu Kitahara; Shinichiro Shimamatsu; Yosuke Morodomi; Tetsuzo Tagawa; Yoshihiko Maehara
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-01-26       Impact factor: 1.520

2.  Pattern of postoperative recurrence and hepatic and/or pulmonary resection for liver and/or lung metastases from esophageal carcinoma.

Authors:  Hirofumi Ichida; Hiroshi Imamura; Jiro Yoshimoto; Hiroyuki Sugo; Yoshiaki Kajiyama; Masahiko Tsurumaru; Kenji Suzuki; Yoichi Ishizaki; Seiji Kawasaki
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

3.  Thoracoscopic resection of solitary lung metastases evaluated by using thin-section chest computed tomography: is thoracoscopic surgery still a valid option?

Authors:  Kook Nam Han; Chang Hyun Kang; In Kyu Park; Young Tae Kim
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-07

4.  Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis.

Authors:  Jun Fan; Dali Chen; Heng Du; Cheng Shen; Guowei Che
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 5.  Current status of pulmonary metastasectomy from primary epithelial tumors.

Authors:  Tokujiro Yano; Fumihiro Shoji; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

6.  Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: experience from a single institution.

Authors:  Yoshiki Kozu; Hiroshi Sato; Yasuhiro Tsubosa; Hirofumi Ogawa; Hirofumi Yasui; Haruhiko Kondo
Journal:  J Cardiothorac Surg       Date:  2011-10-12       Impact factor: 1.637

7.  Is open surgery necessary for metastatic pulmonary tumors evaluated with thorax tomography?

Authors:  Hüseyin Çakmak; Arif Osman Tokat; Sezgin Karasu
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

8.  Pneumonectomy in pulmonary metastasis.

Authors:  Noriyuki Matsutani; Sakae Okumura; Ichiro Yoshino; Norihiko Ikeda; Yuichi Ozeki; Masafumi Kawamura
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

9.  The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study.

Authors:  Manabu Adachi; Mika Mizuno; Hiroko Mitsui; Hiroaki Kajiyama; Shiro Suzuki; Ryuichiro Sekiya; Fumi Utsumi; Kiyosumi Shibata; Tetsuo Taniguchi; Koji Kawaguchi; Kohei Yokoi; Fumitaka Kikkawa
Journal:  Nagoya J Med Sci       Date:  2015-08       Impact factor: 1.131

10.  Surgical approach and outcomes for treatment of pulmonary metastases.

Authors:  Xiaodong Su; Guowei Ma; Xu Zhang; Hao Long; Tie-Hua Rong
Journal:  Ann Thorac Med       Date:  2013-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.